PCL/PEG copolymeric nanoparticles: Potential nanoplatforms for anticancer agent delivery

Current Drug Targets

Volumn 12, Issue 8, 2011, Pages 1131-1150

  Gou, Ma Ling ^a   Wei, Xia Wei ^a   Men, Ke ^a   Wang, Bi Lan ^a   Luo, Feng ^a   Zhao, Xia ^a   Wei, Yu Quan ^a   Qian, Zhi Yong ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Biodegradable polymer; Cancer; Diagnostic agent; Drug delivery system; Gene delivery; Nanoparticle; Poly( caprolactone) poly(ethylene glycol) (PCL PEG) copolymers; Vaccine

Indexed keywords

ANTINEOPLASTIC AGENT; DIAGNOSTIC AGENT; EPSILON CAPROLACTONE ETHYLENE GLYCOL COPOLYMER; MACROGOL; NANOPARTICLE; POLYCAPROLACTONE; UNCLASSIFIED DRUG; VACCINE;

DRUG DELIVERY SYSTEM; DRUG SOLUBILITY; GENE TARGETING; GENE THERAPY; HUMAN; HYDROPHOBICITY; NANOPHARMACEUTICS; NANOTECHNOLOGY; NEOPLASM; NONHUMAN; REVIEW;

ANTINEOPLASTIC AGENTS; BIOCOMPATIBLE MATERIALS; CHEMISTRY, PHARMACEUTICAL; DRUG CARRIERS; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; ETHYLENE GLYCOLS; HUMANS; NANOPARTICLES; NEOPLASMS; POLYESTERS; SOLUBILITY;

EID: 79959343424     PISSN: 13894501     EISSN: 18735592     Source Type: Journal    
DOI: 10.2174/138945011795906642     Document Type: Review

References (187)

1. Allen TM, Cullis PR. Drug delivery systems: entering the mainstream. Science 2004; 303: 1818-22.
2. Wang X, Yang L, Chen Z, Shin DM. Application of Nanotechnology in Cancer Therapy and Imaging. CA Cancer J Clin 2008; 58: 97-110.
3. Service RF. Nanotechnology takes aim at cancer. Science 2005; 310: 1132-4.
4. Nie S, Xing Y, Kim GJ, Simons JW. Nanotechnology Applications in Cancer. Annu Rev Biomed Eng 2007; 9: 257-88.
5. Ferrari M. Cancer nanotechnology: opportunities and challenges. Nat Rev Cancer 2005; 5: 161-71.
6. Srinivas PR, Barker P, Srivastava S. Nanotechnology in early detection of cancer. Lab Invest 2002; 82: 657-62.
7. Wagner V, Dullaart A, Bock AK, Zweck A. The emerging nanomedicine landscape. Nat Biotech 2006; 24: 1211-7.
8. Kwon GS, Okano T. Polymeric micelles as new drug carriers. Adv Drug Deliv Rev 1996; 21: 107-16.
9. Ganta S, Devalapally H, Shahiwala A, Amiji M. A review of stimuli-responsive nanocarriers for drug and gene delivery. J Control Release 2008; 126: 187-204.
10. Park JH, Lee S, Kim JH, Park K, Kim K, Kwon IC. Polymeric nanomedicine for cancer therapy. Prog Polym Sci 2008; 33: 113-37.
11. Sinha VR, Bansal K, Kaushik R, Kumria R, Trehan A. Poly-e- caprolactone microspheres and nanospheres: an overview. Int J Pharm 2004; 278: 1-23.
12. Yang J, Park SB, Yoon HG, Huh YM, Haam S. Preparation of poly e-caprolactone nanoparticles containing magnetite for magnetic drug carrier. Int J Pharm 2006; 324: 185-90.
13. Chawla JS, Amiji MM. Biodegradable poly(e-caprolactone) nanoparticles for tumor-targeted delivery of tamoxifen. Int J Pharm 2002; 249: 127-38.
14. Chawla JS, Amiji MM. Cellular uptake and concentrations of tamoxifen upon administration in poly(e-caprolactone) nanoparticles. AAPS J 2003; 5: 28-34.
15. Wei XW, Gong CY, Gou ML, et al. Biodegradable poly(e- caprolactone)-poly(ethylene glycol) copolymers as drug delivery system. Int J Pharm 2009; 381: 1-18.
16. Perret R, Skoulios A. Synthèse et caractérisation de copolymères séquencés polyoxyéthylène/poly-e-caprolactone. Makromol Chem 1972; 156: 43-156.
17. Cerrai P, Tricoli M, Andruzzi F, Paci M, Paci M. Polyether- polyester block copolymers by non-catalysed polymerization of e- caprolactone with poly(ethylene glycol). Polymer 1989; 30: 338-43.
18. Piao L, Dai Z, Deng M, Chen X, Jing X. Synthesis and characterization of PCL/PEG/PCL triblock copolymers by using calcium catalyst. Polymer 2003; 44: 2025-31.
19. Nagasaki Y, Okada T, Scholz C, Iijima M, Kato M, Kataoka K. The reactive polymeric micelle based on an aldehyde-ended poly(ethylene glycol)/poly(lactide) block copolymer. Macromolecules 1998; 31: 1473-9.
20. Dobrzynski P, Kasperczyk J, Bero M. Application of calcium acetylacetonate to the polymerization of glycolide and copolymerization of glycolide with e-caprolactone and L-lactide. Macromolecules 1999; 32: 4735-7.
21. Kobayashi S, Uyama H, Kimura S. Enzymatic polymerization. Chem Rev 2001; 101: 3793-818.
22. Connor EF, Nyce GW, Myers M, Mock A, Hedrick JL. First example of N-heterocyclic carbenes as catalysts for living polymerization: organocatalytic ring-opening polymerization of cyclic esters. J Am Chem Soc 2002; 124: 914-5.
23. Myers M, Connor EF, Glauser T, Mock A, Nyce GW, Hedrick JL. Phosphines: nucleophilic organic catalysts for the controlled ringopening polymerization of lactides. J Polym Sci Part A: Polym Chem 2002; 40: 844-51.
24. Nyce GW, Glauser T, Connor EF, Mock A, Waymouth RM, Hedrick JL. In situ generation of carbenes: a general and versatile platform for organocatalytic living polymerization. J Am Chem Soc 2003; 125: 3046-56.
25. Deng XM, Xiong CD, Cheng LM, Xu RP. Synthesis and characterization of block copolymers from d, l-lactide and poly (ethylene glycol) with stannous chloride. J Polym Sci Part C: Polym Lett 1990; 28: 411-6.
26. Choi CG, Chae SY, Kim TH, et al. Synthesis and physicochemical characterization of amphiphilic block copolymer self-aggregates formed by poly(ethylene glycol)-block-poly(e-caprolactone). J Appl Spectrosc 2006; 99: 3520-7.
27. Ma Z, Haddadi A, Molavi O, Lavasanifar A, Lai R, Samuel J. Micelles of poly(ethylene oxide)-b-poly(e-caprolactone) as vehicles for the solubilization, stabilization, and controlled delivery of curcumin. J Biomed Mater Res A 2007; 86A: 300-10.
28. Gou ML, Qian ZY, Wang H, et al. Preparation and characterization of magnetic poly(e-caprolactone)-poly(ethylene glycol)-poly(e- caprolactone) microspheres. J Mater Sci: Mater Med 2008; 19: 1033-41.
29. Gong CY, Qian ZY, Liu CB, et al. A thermosensitive hydrogel based on biodegradable amphiphilic poly(ethylene glycol)- polycaprolactone-poly(ethylene glycol) block copolymers. Smart Mater Struct 2007; 16: 927-33.
30. Signori F, Chiellini F, Solaro R. New self-assembling biocompatible-biodegradable amphiphilic block copolymers. Polymer 2005; 46: 9642-52.
31. Zhang Y, Zhuo RX. Synthesis and in vitro drug release behavior of amphiphilic triblock copolymer nanoparticles based on poly (ethylene glycol) and polycaprolactone. Biomaterials 2005; 26: 6736-42.
32. Kim KH, Cui GH, Lim HJ, June H, Cheol-Hee A, Jo WH. Synthesis and micellization of star-shaped poly(ethylene glycol)- block-poly(e-caprolactone). Macromol Chem Phys 2004; 205: 1684-92.
33. Quaglia F, Ostacolo L, Rosa GD, et al. Nanoscopic core-shell drug carriers made of amphiphilic triblock and star-diblock copolymers. Int J Pharm 2006; 324: 56-66.
34. Lu CF, Guo SR, Zhang YQ, Yin M. Synthesis and aggregation behavior of four types of different shaped PCL-PEG block copolymers. Polym Int 2006; 55: 694-700.
35. Zhang J, Gou ML, Qian ZY, et al. Core-cross linked PCL-PEGPCL nanoparticles for drug delivery in vitro. J Nanosci Nanotechnol 2011; in press.
36. Wang F, Bronich TK, Kabanov AV, Rauh RD, Roovers J. Synthesis and evaluation of a star amphiphilic block copolymer from poly(e-caprolactone) and poly(ethylene glycol) as a potential drug delivery carrier. Bioconjug Chem 2005; 16: 397-405.
37. Wang F, Bronich TK, Kabanov AV, Rauh RD, Roovers J. Synthesis and characterization of star poly(e-caprolactone)-bpoly(ethylene glycol) and poly(l-lactide)-b-poly(ethylene glycol) copolymers: evaluation as drug delivery carriers. Bioconjug Chem 2008; 19: 1423-9.
38. Peng C, Shieh M, Tsai M, Chang C, Lai P. Self-assembled starshaped chlorin-core poly(e-caprolactone)-poly(ethylene glycol) diblock copolymer micelles for dual chemo-photodynamic therapies. Biomaterials 2008; 29: 3599-608.
39. Qiu F, Feng J, Wu DQ, Zhang XZ, Zhuo RX. Nanosized micelles self-assembled from amphiphilic dextran-graftmethoxypolyethylene glycol/poly(e-caprolactone) copolymers. Eur Polym J 2009; 45: 1024-31.
40. O'Donnell PB, McGinity JW. Preparation of microspheres by the solvent evaporation technique. Adv Drug Deliv Rev 1997; 28: 25-42.
41. Sergio F, Hans PM, Bruno G. Microencapsulation by solvent extraction/evaporation: reviewing the state of the art of microsphere preparation process technology. J Control Release 2005; 102: 313-32.
42. Couvreura P, Blanco-Prietoa MJ, Puisieuxa F, Roquesb B, Fattal E. Multiple emulsion technology for the design of microspheres containing peptides and oligopeptides. Adv Drug Deliv Rev 1997; 28: 85-96.
43. Gou ML, Li XY, Dai M, et al. A novel injectable local hydrophobic drug delivery system: Biodegradable nanoparticles in thermo-sensitive hydrogel. Int J Pharm 2008; 359: 228-33.
44. Gou ML, Wu L, Yin QQ, et al. Transdermal anaesthesia with lidocaine nano-formulation pretreated with low-frequency ultrasound in rats model. J Nanosci Nanotechnol 2009; 9: 6360-5.
45. Yang YY, Chung TS, Ng NP. Morphology, drug distribution, and in vitro release profiles of biodegradable polymeric microspheres containing protein fabricated by double-emulsion solvent extraction/evaporation method. Biomaterials 2001; 22: 231-41.
46. Nihant N, Schugens C, Grandfils C, Jérôme C, Teyssié P. Polylactide microparticles prepared by double emulsion/evaporation technique. i. effect of primary emulsion stability. Pharm Res 1994; 11: 1479-84.
47. Lamprecht A, Ubrich N, Hombreiro Pérez M, Lehr CM, Hoffman M, Maincent P. Biodegradable monodispersed nanoparticles prepared by pressure homogenization-emulsification. Int J Pharm 1999; 184: 97-105.
48. Langer R, Folkman J. Polymers for the sustained release of proteins and other macromolecules. Nature 1976; 263: 797-800.
49. Jia WJ, Gu YC, Gou ML, et al. Preparation of Biodegradable Polycaprolactone/Poly (ethylene glycol)/Polycaprolactone (PCEC) Nanoparticles. Drug Deliver 2008; 15: 409-16.
50. Zhou SB, Deng XM, Yang H. Biodegradable poly(e-caprolactone)- poly(ethylene glycol) block copolymers: characterization and their use as drug carriers for a controlled delivery system. Biomaterials 2003; 24: 3563-70.
51. Lamprecht A, Ubrich N, Pérez MH, Lehr CM, Hoffman M, Maincent P. Influences of process parameters on nanoparticle preparation performed by a double emulsion pressure homogenization technique. Int J Pharm 2000; 196: 177-82.
52. Ryu JG, Jeong YI, Kim IS, Lee JH, Nah JW, Kim SH. Clonazepam release from core-shell type nanoparticles of poly(o-caprolactone): poly(ethylene glycol): poly(e-caprolactone) triblock copolymers. Int J Pharm 2000; 200: 231-42.
53. Kim SY, Shin IG, Lee YM, Cho CS, Sung YK. Methoxy poly(ethylene glycol) and e-caprolactone amphiphilic block copolymeric micelle containing indomethacin. II. Micelle formation and drug release behaviours. J Control Release 1998; 51: 13-22.
54. Shin IG, Kim SY, Lee YM, Cho CS, Sung YK. Methoxy poly(ethylene glycol)/e-caprolactone amphiphilic block copolymeric micelle containing indomethacin. I. Preparation and characterization. J Control Release 1998; 51: 1-11.
55. Shi B, Fang C, You M, Zhang Y, Fu S, Pei YG. Stealth MePEG- PCL micelles: effects of polymer composition on micelle physicochemical characteristics, in vitro drug release, in vivo pharmacokinetics in rats and biodistribution in S180 tumor bearing mice. Colloid Polym Sci 2005; 283: 954-67.
56. Verger MLL, Fluckiger L, Kim YI, Hoffman M, Maincent P. Preparation and characterization of nanoparticles containing an antihypertensive agent. Eur J Pharm Biopharm 1998; 46: 137-43.
57. Gou ML, Zheng L, Peng XY, et al. Poly(e-caprolactone)- poly(ethylene glycol)-poly(e-caprolactone) (PCL-PEG-PCL) nanoparticles for honokiol delivery in vitro. Int J Pharm 2009; 375: 170-6.
58. Ameller T, Marsaud V, Legrand P, Gref R, Barratt G, Renoir JM. Polyester-Poly(Ethylene Glycol) nanoparticles loaded with the pure antiestrogen RU 58668: physicochemical and opsonization properties. Pharm Res 2003; 20: 1063-70.
59. Jeong YI, Kang MK, Sun HS, et al. All-trans-retinoic acid release from core-shell type nanoparticles of poly(e-caprolactone)/poly (ethylene glycol) diblock copolymer. Int J Pharm 2004; 273: 95-107.
60. Layre A, Couvreur P, Chacun H, et al. Novel composite core-shell nanoparticles as busulfan carriers. J Control Release 2006; 111: 271-80.
61. Gindy M, Ji S, Hoye T, Panagiotopoulos A, Prudhomme R. Preparation of poly(ethylene glycol) protected nanoparticles with variable bioconjugate ligand density. Biomacromolecules 2008; 9: 2705-11.
62. Karnik R, Gu F, Basto P, et al. Microfluidic platform for controlled synthesis of polymeric nanoparticles. Nano Lett 2008; 8: 2906-12.
63. Tom JW, Debenedetti PG. Particle formation with supercritical fluids-a review. J Aerosol Sci 1991; 22: 555-84.
64. Tyrrell Z, Winoto W, Shen Y, Radosz M. Block copolymer micelles formed in supercritical fluid can become waterdispensable nanoparticles: Poly(ethylene glycol)-block-Poly(e- caprolactone) in trifluoromethane. Ind Eng Chem Res 2009; 48: 1928-32.
65. Allemann E, Gurny R, Doelker E. Preparation of aqueous polymeric nanodispersions by a reversible salting-out process: influence of process parameters on particle size. Int J Pharm 1992; 87: 247-53.
66. Wei X, Gong C, Shi S, et al. Self-assembled honokiol-loaded micelles based on poly(e-caprolactone)-poly(ethylene glycol)- poly(e-caprolactone) copolymer. Int J Pharm 2009; 369: 170-5.
67. Göpferich A. Mechanisms of polymer degradation and erosion. Biomaterials 1996; 17: 103-14.
68. Qian Z, Li S, He Y, Zhang H, Liu X. Hydrolytic degradation study of biodegradable polyesteramide copolymers based on e- caprolactone and 11-aminoundecanoic acid. Biomaterials 2004; 25: 1975-81.
69. Goldberg D. A review of the biodegradability and utility of poly(caprolactone). J Polym Environment 1995; 3: 61-7.
70. Ohtaki A, Akakura N, Nakasaki K. Effects of temperature and inoculum on the degradability of poly-e-caprolactone during composting. Polym Degrad Stab 1998; 62: 279-84.
71. Rhee SH. Effect of molecular weight of poly(-caprolactone) on interpenetrating network structure, apatite-forming ability, and degradability of poly(-caprolactone)/silica nano-hybrid materials. Biomaterials 2003; 24: 1721-7.
72. Chen DR, Bei JZ, Wang SG. Polycaprolactone microparticles and their biodegradation. Polym Degrad Stab 2000; 67: 455-9.
73. Sun H, Mei L, Song C, Cui X, Wang P. The in vivo degradation, absorption and excretion of PCL-based implant. Biomaterials 2006; 27: 1735-40.
74. Li S, Garreau H, Pauvert B, McGrath J, Toniolo A, Vert M. Enzymatic Degradation of Block Copolymers Prepared from e- Caprolactone and Poly(ethylene glycol). Biomacromolecules 2002; 3: 525-30.
75. He F, Li S, Vert M, Zhuo R. Enzyme-catalyzed polymerization and degradation of copolymers prepared from e-caprolactone and poly(ethylene glycol). Polymer 2003; 44: 5145-51.
76. Huang MH, Li S, Hutmacher DW, et al. Degradation and cell culture studies on block copolymers prepared by ring opening polymerization of e-caprolactone in the presence of poly(ethylene glycol). J Biomed Mater Res A 2004; 69A: 417-27.
77. Bei JZ, Li JM, Wang ZF, Le JC, Wang SG. Polycaprolactone- poly(ethylene-glycol) Block Copolymer. IV: biodegradation Behavior in vitro and in vivo. Polym Adv Technol 1997; 8: 693-6.
78. Shen C, Guo S, Lu C. Degradation behaviors of monomethoxy poly(ethylene glycol)-b-poly(e-caprolactone) nanoparticles in aqueous solution. Polym Adv Technol 2008; 19: 66-72.
79. Shen C, Guo S, Lu C. Degradation behaviors of star-shaped poly(ethylene glycol)-poly (e-caprolactone) nanoparticles in aqueous solution. Polym Degrad Stab 2007; 92: 1891-8.
80. Jiang Z, Zhu Z, Liu C, Hu Y, Wu W, Jiang X. Non-enzymatic and enzymatic degradation of poly(ethylene glycol)-b-poly-(e- caprolactone) diblock copolymer micelles in aqueous solution. Polymer 2008; 49: 5513-9.
81. Lin WJ, Chen YC, Lin CC, Chen CF, Chen JW. Characterization of pegylated copolymeric micelles and in vivo pharmacokinetics and biodistribution studies. J Biomed Mater Res B 2006; 77B: 188-94.
82. Monfardini C, Veronese FM. Stablization of substances in circulation. Bioconjug Chem 1998; 9: 418-50.
83. Fang F, Gong CY, Dong PW, et al. Acute toxicity evaluation of in situ gel-forming controlled drug delivery system based on biodegradable poly(e-caprolactone)-poly(ethylene glycol)-poly(e- caprolactone) copolymer. Biomed Material 2009; 4: 025002 (7pp).
84. Huang Y, Gao H, Gou M, et al. Acute toxicity and genotoxicity studies on poly(e-caprolactone)-poly(ethylene glycol)-poly(e- caprolactone) nanomaterials. Mut Res/Genetic Tox Envir Mut 2010; 696: 101-6.
85. Kim SY, Lee YM, Baik DJ, Kang JS. Toxic characteristics of methoxy poly(ethylene glycol)/poly(e-caprolactone) nanospheres; in vitro and in vivo studies in the normal mice. Biomaterials 2003; 24: 55-63.
86. Allen C, Yu Y, Eisenberg A, Maysinger D. Cellular internalization of PCL20-b-PEO44 block copolymer micelles. BBA- Biomem 1999; 1421: 32-8.
87. Luo L, Tam J, Maysinger D, Eisenberg A. Cellular internalization of Poly(ethylene oxide)-b-poly(e-caprolactone) diblock copolymer micelles. Bioconjugate Chem 2002; 13: 1259-65.
88. Savic R, Luo L, Eisenberg A, Maysinger D. Micellar nanocontainers distribute to defined cytoplasmic organelles. Science 2003; 300: 615-8.
89. Mahmud A, Lavasanifar A. The effect of block copolymer structure on the internalization of polymeric micelles by human breast cancer cells. Colloid Surface B: Biointerface 2005; 45: 82-9.
90. Hu Y, Xie J, Tong YW, Wang CH. Effect of PEG conformation and particle size on the cellular uptake efficiency of nanoparticles with the HepG2 cells. J Control Release 2007; 118: 7-17.
91. Jette KK, Law D, Schmitt EA, Kwon GS. Preparation and drug loading of poly(Ethylene Glycol)-block-Poly(e-Caprolactone) micelles through the evaporation of a cosolvent azeotrope. Pharm Res 2004; 21: 1184-91.
92. Liu J, Zeng F, Allen C. In vivo fate of unimers and micelles of a poly(ethylene glycol)-block-poly(caprolactone) copolymer in mice following intravenous administration. Eur J Pharm Biopharm 2007; 65: 309-19.
93. Xu P, Tang H, Li S, et al. Enhanced stability of core-surface crosslinked micelles fabricated from amphiphilic brush copolymers. Biomacromolecules 2004; 5: 1736-44.
94. Tufts Center for the Study of Drug Development, Tufts University (Boston, Mass, USA) http://www.csdd.tufts.edu
95. Saffie-Sieverb R, Ogden J, Parry-Billings M. Nanotechnology approaches to solving the problems of poorly water-soluble drugs. Drug Discov World 2005; 71-6.
96. Ibrahim NK, Desai N, Legha S, et al. Phase I and pharmacokinetic study of ABI-007, a cremophor-free, protein-stabilized, nanoparticle formulation of paclitaxel. Clin Cancer Res 2002; 8: 1038-44.
97. Kim SY, Lee YM. Taxol-loaded block copolymer nanospheres composed of methoxy poly(ethylene glycol) and poly(epsiloncaprolactone) as novel anticancer drug carriers, Biomaterials 2001; 22: 1697-704.
98. Letchford K, Liggins R, Wasan KM, Burt H. In vitro human plasma distribution of nanoparticulate paclitaxel is dependent on the physicochemical properties of poly(ethylene glycol)-blockpoly(caprolactone) nanoparticles. Eur J Pharm Biopharm 2009; 71: 196-206.
99. Forrest ML, Yñez JA, Remsberg CM, Ohgami Y, Kwon GS, Davies NM. Paclitaxel prodrugs with sustained release and high solubility in Poly(ethylene glycol)-b-poly(e-caprolactone) micelle nanocarriers: pharmacokinetic disposition, tolerability, and cytotoxicity. Pharm Res 2008; 25: 194-206.
100. Carstens MG, de Jong PHJLG, van Nostrum CF, et al. The effect of core composition in biodegradable oligomeric micelles as taxane formulations. Eur J Pharm Biopharm 2008; 68: 596-606.
101. Danhier F, Magotteaux N, Ucakar B, Lecouturier N, Brewster M, Préat V. Novel self-assembling PEG-p-(CL-co-TMC) polymeric micelles as safe and effective delivery system for Paclitaxel. Eur J Pharm Biopharm 2009; 73: 230-8.
102. Zhang Y, Wang C, Yang W, Shi B, Fu S. Tri-component diblock copolymers of poly(ethylene glycol)-poly(e-caprolactonecolactide): synthesis, characterization and loading camptothecin. Colloid Polym Sci 2005; 283: 1246-52.
103. Zhang L, Hu Y, Jiang X, Yang C, Lu W, Yang YH. Camptothecin derivative-loaded poly(caprolactone-co-lactide)-b-PEG-bpoly(caprolactone-co-lactide) nanoparticles and their biodistribution in mice. J Control Release 2004; 96: 135-48.
104. Shenoy DB, Amiji MM. Poly(ethylene oxide)-modified poly(e- caprolactone) nanoparticles for targeted delivery of tamoxifen in breast cancer. Int J Pharm 2005; 293: 261-70.
105. Xu P, Van Kirk EA, Li S, et al. Highly stable core-surfacecrosslinked nanoparticles as cisplatin carriers for cancer chemotherapy. Colloid Surface B: Biointerfaces 2006; 48: 50-7.
106. Molavi O, Ma Z, Mahmud A, et al. Polymeric micelles for the solubilization and delivery of STAT3 inhibitor cucurbitacins in solid tumors. Int J Pharm 2008; 347: 118-27.
107. Forrest ML, Zhao A, Won CY, Malick AW, Kwon GS. Lipophilic prodrugs of Hsp90 inhibitor geldanamycin for nanoencapsulation in poly(ethylene glycol)-b-poly(e-caprolactone) micelles. J Control Release 2006; 116: 139-49.
108. Gou ML, Zheng XL, Men K, et al. Self-assembled hydrophobic honokiol loaded MPEG-PCL diblock copolymer micelles. Pharm Res 2009; 26: 2164-73.
109. Ameller T, Marsaud V, Legrand P, Gref R, Renoir JM. Pure antiestrogen RU 58668-loaded nanospheres: morphology, cell activity and toxicity studies. Eur J Pharm Sci 2004; 21: 361-70.
110. Yang Y, Hua C,Dong CM. Synthesis, self-assembly, and in vitro doxorubicin release behavior of dendron-like/linear/dendron-like Poly(e-caprolactone)-b-Poly(ethylene glycol)-b-Poly(e-caprolactone) triblock copolymers. Biomacromolecule 2009; 10: 2310-8.
111. Gou ML, Gong CY, Zhang J, et al. Polymeric matrix for drug delivery: Honokiol-loaded PCL-PEG-PCL nanoparticles in PEGPCL- PEG thermosensitive hydrogel. J Biomed Mater Res A 2010; 93A: 219-26.
112. Gong CY, Shi S, Wang XH, et al. Novel composite drug delivery system for honokiol delivery: self-assembled Poly(ethylene glycol)-Poly(e-caprolactone)-Poly(ethylene glycol) micelles in thermosensitive Poly(ethylene glycol)-Poly(e-caprolactone)- Poly(ethylene glycol) hydrogel. J Phys Chem B 2009; 113: 10183-8.
113. Fang F, Gong CY, Qian ZY, et al. Honokiol nanoparticles in thermosensitive hydrogel: therapeutic effects on malignant pleural effusion. ACS Nano 2009; 3: 4080-8.
114. Matsumura Y, Maeda H. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res 1986; 46: 6387-92.
115. Hobbs SK, Monsky WL, Yuan F, et al. Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment. Proc Natl Acad Sci USA 1998; 95: 4607-12.
116. Otsuka H, Nagasaki Y, Kataoka K. PEGylated nanoparticles for biological and pharmaceutical Applications. Adv Drug Deliver Rev 2003; 55: 403-19.
117. Gou ML, Zheng XL, Men K, et al. Poly(e-caprolactone)/ Poly(ethylene glycol)/Poly(e-caprolactone) nanoparticles: preparation, characterization, and application in doxorubicin delivery. J Phys Chem B 2009; 113: 12928-33.
118. Shuai X, Ai H, Nasongkla N, Kim S, Gao J. Micellar carriers based on block copolymers of poly(e-caprolactone) and poly(ethylene glycol) for doxorubicin delivery. J Control Release 2004; 98: 415-26.
119. Shen Y, Zhan Y, Tang J, et al. Multifunctioning pH-responsive nanoparticles from hierarchical self-assembly of polymer brush for cancer drug delivery. AIChE J 2008; 54: 2979-89.
120. Van Butsele K, Cajot S, Van Vlierberghe S, et al. pH-responsive flower-type micelles formed by a biotinylated Poly(2-vinylpyridine)- block-poly(ethylene oxide)-block-poly(e-caprolactone) triblock copolymer. Adv Funct Mater 2009; 19: 1416-25.
121. Shenoy D, Little S, Langer R, Amiji M. Poly(Ethylene Oxide)- modified Poly(ß-Amino Ester) nanoparticles as a pH-sensitive system for tumor-targeted delivery of hydrophobic drugs: part 2. in vivo distribution and tumor localization studies. Pharm Res 2005; 22: 2107-14.
122. Tang LY, Wang YC, Li Y, Du JZ, Wang J. Shell-detachable micelles based on disulfide-linked block copolymer as potential carrier for intracellular drug delivery. Bioconjugate Chem 2009; 20: 1095-9.
123. Sun H, Guo B, Cheng R, Meng F, Liu H, Zhong Z. Biodegradable micelles with sheddable poly(ethylene glycol) shells for triggered intracellular release of doxorubicin. Biomaterials 2009; 30: 6358-66.
124. Rutnakornpituk M, Meerod S, Boontha B, Wichai U. Magnetic core-bilayer shell nanoparticle: A novel vehicle for entrapment of poorly water-soluble drugs. Polymer 2009; 50: 3508-15.
125. Meerod S, Tumcharern G, Wichai U, Rutnakornpituk M. Magnetite nanoparticles stabilized with polymeric bilayer of poly(ethylene glycol) methyl ether-poly(e-caprolactone) copolymers. Polymer 2008; 49: 3950-6.
126. Yamamoto Y, Nagasaki Y, Kato Y, Sugiyama Y, Kataoka K. Long-circulating poly (ethylene glycol)-poly (D,L-lactide) block copolymer micelles with modulated surface charge. J Control Release 2001; 77: 27-38.
127. Stohrer M, Boucher Y, Stangassinger M, Jain RK. Oncotic pressure in solid tumors is elevated. Cancer Res 2000; 60: 4251-5.
128. Allen TM. Ligand-targeted therapeutics in anticancer therapy. Nat Rev Cancer 2002; 2: 750-63.
129. Vicent MJ, Duncan R. Polymer conjugates: nanosized medicines for treating cancer. Trends Biotechnol 2006; 24: 39-47.
130. Seymour LW, Ferry DR, Anderson D, et al. Hepatic drug targeting: phase I evaluation of polymer-bound doxorubicin. J Clin Oncol 2002; 20: 1668-76.
131. Sugano M, Egilmez NK, Yokota SJ, et al. Antibody targeting of doxorubicin-loaded liposomes suppresses the growth and metastatic spread of established human lung tumor xenografts in severe combined immunodeficient mice. Cancer Res 2000; 60: 6942-9.
132. Brannon-Peppas L, Blanchette JO. Nanoparticle and targeted systems for cancer therapy. Adv Drug Deliv Rev 2004; 56: 1649-59.
133. Yang J, Cho EJ, Seo S, et al. Enhancement of cellular binding efficiency and cytotoxicity using polyethylene glycol base triblock copolymeric nanoparticles for targeted drug delivery. J Biomed Mater Res A 2008; 84A: 273-80.
134. Park EK, Kim SY, Lee SB, Lee YM. Folate-conjugated methoxy poly(ethylene glycol)/poly(e-caprolactone) amphiphilic block copolymeric micelles for tumor-targeted drug delivery. J Control Release 2005; 109: 158-68.
135. Park EK, Lee SB, Lee YM. Preparation and characterization of methoxy poly(ethylene glycol)/poly(e-caprolactone) amphiphilic block copolymeric nanospheres for tumor-specific folate-mediated targeting of anticancer drugs. Biomaterials 2005; 26: 1053-61.
136. Chen S, Zhang XZ, Cheng SX, Zhuo RX, Gu ZW. functionalized amphiphilic hyperbranched polymers for targeted drug delivery. Biomacromolecules 2008; 9: 2578-85.
137. Yang X, Deng W, Fu L, et al. Folate-functionalized polymeric micelles for tumor targeted delivery of a potent multidrugresistance modulator FG020326. J Biomed Mater Res A 2008; 86A: 48-60.
138. Yang X, Chen Y, Yuan R, et al. Folate-encoded and Fe3O4-loaded polymeric micelles for dual targeting of cancer cells. Polymer 2008; 49: 3477-85.
139. Nasongkla N, Shuai XT, Ai Hua, et al. cRGD-Functionalized Polymer Micelles for Targeted Doxorubicin Delivery. Angew Chem Int Ed 2004; 43: 6323-7.
140. Xiong XB, Mahmud A, Uludag H, Lavasanifar A. Conjugation of arginine-glycine-aspartic acid peptides to poly(ethylene oxide)-bpoly (e-caprolactone) micelles for enhanced intracellular drug delivery to metastatic tumor cells. Biomacromolecules 2007; 8: 874-84.
141. Xiong XB, Ma Z, Lai R, Lavasanifar A. The therapeutic response to multifunctional polymeric nano-conjugates in the targeted cellular and subcellular delivery of doxorubicin. Biomaterials 2010; 31: 757-68.
142. Wang YC, Liu XQ, Sun TM, Xiong MH, Wang J. Functionalized micelles from block copolymer of polyphosphoester and poly(e- caprolactone) for receptor-mediated drug delivery. J Control Release 2008; 128: 32-40.
143. Noh T, Kook YH, Park C, et al. Block copolymer micelles conjugated with anti-EGFR antibody for targeted delivery of anticancer drug. J Polym Sci Part A: Polym Chem 2008; 46: 7321-31.
144. Edelstein ML, Abedi MR, Wixon J, Edelstein RM. Gene therapy clinical trials worldwide 1989-2004 - an overview. J Gene Med 2004; 6: 597-602.
145. Anderson DG, Peng W, Akinc A, et al. A polymer library approach to suicide gene therapy for cancer. Proc Natl Acad Sci USA 2004; 101: 16028-33.
146. Veiseh O, Kievit FM, Gunn JW, Ratner BD, Zhang M. A ligandmediated nanovector for targeted gene delivery and transfection in cancer cells. Biomaterials 2009; 30: 649-57.
147. Calvo MC, Thrasher A, Mailio F. The future of gene therapy. Nature 2004; 427: 779-81.
148. Relph K, Harrington K, Pandha H. Recent developments and current status of gene therapy using viral vectors in the United Kingdom. BMJ 204; 329: 839-42.
149. Glover DJ, Lipps HJ, Jans DA. Towards safe, nove-viral therapeutic gene experession in humans. Nat Rev Genet 2005; 6: 299-310.
150. Ferber D. Gene therapy: safer and virus-free? Science 2001; 294: 1638-42.
151. Li SD, Huang L. Non-viral is superior to viral gene delivery. J Control Release 2007; 123: 181-3.
152. Jang JS, Kim SY, Lee SB, Kim KO, Han JS, Lee YM. Poly(ethylene glycol)/poly(e-caprolactone) diblock copolymeric nanoparticles for non-viral gene delivery: The role of charge group and molecular weight in particle formation, cytotoxicity and transfection. J Control Release 2006; 113: 173-82.
153. Shuai X, Merdan T, Unger F, Wittmar M, Kissel T. novel biodegradable ternary copolymers hy-PEI-g-PCL-b-PEG: synthesis, characterization, and potential as efficient nonviral gene delivery vectors. Macromolecules 2003; 36: 5751-9.
154. Huang MJ, Gou ML, Qian ZY, et al. One-step preparation of poly(e-caprolactone)-poly(ethylene glycol)-poly(e-caprolactone) nanoparticles for plasmid DNA delivery. J Biomed Mater Res A 2008; 86A: 979-86.
155. Zhao J, Gou ML, Dai M, et al. Preparation, characterization, and in vitro cytotoxicity study of cationic PCL-Pluronic-PCL (PCFC) nanoparticles for gene delivery. J Biomed Mater Res A 2009; 90A: 506-13.
156. Shi S, Guo QF, Kan B, et al. Polyethyleneimine(PCFC-g-PEI), Part 1, synthesis, cytotoxicity, and in vitro transfection study. BMC Biotechnol 2009; 9: 65.
157. Guo QF, Shi S, Wang XH, et al. Synthesis of a novel biodegradable poly(ester amine) (PEAs) copolymer based on lowmolecular- weight polyethyleneimine for gene delivery. Int J Pharm 2009; 379: 82-9.
158. Sun TM, Du JZ, Yan LF, Mao HQ, Wang J. Self-assembled biodegradable micellar nanoparticles of amphiphilic and cationic block copolymer for siRNA delivery. Biomaterials 2008; 29: 4348-55.
159. Xiong XB, Uludag H, Lavasanifar A. Biodegradable amphiphilic poly(ethylene oxide)-block-polyesters with grafted polyamines as supramolecular nanocarriers for efficient siRNA delivery. Biomaterials 2009; 30: 242-53.
160. Men K, Gou ML, Guo QF, et al. A novel drug and gene codelivery system based on Poly(e-caprolactone)-poly(ethylene glycol)-poly(e-caprolactone) grafted polyethyleneimine micelle. J Nanosci Nanotechnol 2010; 10: 7958-64.
161. Gilboa E. The promise of cancer vaccines. Nat Rev Cancer 2004; 4: 401-11.
162. Wei YQ, Wang QR, Zhao X, et al. Immunotherapy of tumors with xenogeneic endothelial cells as a vaccine. Nat Med 2000; 6: 1160-6.
163. Waldmann TA. Immunotherapy: past, present and future. Nat Med 2003; 9: 269-77.
164. Rosenberg SA, Yang JC, Restifo NP. Cancer immunotherapy: moving beyond current vaccines. Nat Med 2004; 10: 909-15.
165. O'Hagan DT, Valianate NM. Recent advances in the discovery and delivery of vaccine adjuvants. Nat Rev Drug Discov 2003; 2: 727-35.
166. Gupta RK. Aluminum compounds as vaccine adjuvants. Adv Drug Deliver Rev 1998; 32: 155-72.
167. Peek LJ, Middaugh CR, Berkland C. Nanotechnology in vaccine delivery. Adv Drug Deliver Rev 2008; 60: 915-28.
168. Chong CSW, Cao M, Wong WW, et al. Enhancement of T helper type 1 immune responses against hepatitis B virus core antigen by PLGA nanoparticle vaccine delivery. J Control Rel 2005; 102: 85-99.
169. Hanes J, Cleland JL, Langer R. New advances in microspherebased single-dose vaccines. Adv Drug Deliv Rev 1997; 28: 97-119.
170. Giudice EL, Campbell JD. Needle-free vaccine delivery. Adv Drug Deliv Rev 2006; 58: 68-89.
171. Lawson LB, Freytag LC, Clements JD. Use of nanocarriers for transdermal vaccine delivery. Clin Pharmacol Ther 2007; 82: 641-3.
172. des Rieux A, Fievez V, Garinot M, Schneider YJ, Préat V. Nanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approach. J Control Release 2006; 116: 1-27.
173. Vila A, Sánchez A, Janes K, et al. Low molecular weight chitosan nanoparticles as new carriers for nasal vaccine delivery in mice. Eur J Pharm Biopharm 2004; 57: 123-31.
174. Gou ML, Huang MJ, Qian ZY, et al. Preparation of anionic poly(e- caprolactone)-poly(ethylene glycol)-poly(e-caprolactone) copolymeric nanoparticles as basic protein antigen carrier. Growth Factors 2007; 25: 202-8.
175. Gou M, Dai M, Gu Y, et al. BFGF loaded biodegradable PCL- PEG-PCL copolymeric nanoparticles: preparation, in vitro release and immunogenicity study. J Nanosci Nanotechnol 2008; 8: 2357-61.
176. Reddy ST, Swartz MA, Hubbell JA. Targeting dendritic cells with biomaterials: developing the next generation of vaccines. Trend Immunol 2006; 27: 573-9.
177. Gou M, Dai M, Li X, et al. Preparation of mannan modified anionic PCL-PEG-PCL nanoparticles at one-step for bFGF antigen delivery to improve humoral immunity. Colloids Surf B: Biointerf 2008; 64: 135-9.
178. Rieger J, Stoffelbach F, Cui D, et al. Mannosylated Poly(ethylene oxide)-b-Poly(e-caprolactone) diblock copolymers: synthesis, characterization, and interaction with a bacterial lectin. Biomacromolecules 2007; 8: 2717-25.
179. Rieger J, Freichels H, Imberty A, et al. Polyester nanoparticles
180. Ermak TH, Giannasca PJ. Microparticle targeting to M cells. Adv Drug Deliv Rev 1998; 34: 261-83.
181. Garinot M, Fiévez V, Pourcelle V, et al. PEGylated PLGA-based nanoparticles targeting M cells for oral vaccination. J Control Rel 2007; 120: 195-204.
182. Fievez V, Plapied L, des Rieux A, et al. Targeting nanoparticles to M cells with non-peptidic ligands for oral vaccination. Eur J Pharm Biopharm 2009; 73: 16-24.
183. Mottram PL, Leong D, Crimeen-Irwin B, et al. Type 1 and 2 immunity following vaccination is influenced by nanoparticle size: formulation of a model vaccine for respiratory syncytial virus. Mol Pharm 2007; 4: 73-84.
184. Ai H, Flask C, Weinberg B, et al. Magnetite-loaded polymeric micelles as ultrasensitive magnetic-resonance probes. Adv Mater 2005; 17: 1949-52.
185. Torchilin VP. Multifunctional nanocarriers. Adv Drug Deliv Rev 2006; 58: 1532-55.
186. Nasongkla N, Bey E, Ren J, et al. Multifunctional polymeric micelles as cancer-targeted, MRI-ultrasensitive drug delivery systems. Nano Lett 2006; 6: 2427-30.
187. Azzam T, Eisenberg A. monolayer-protected gold nanoparticles by the self-assembly of micellar Poly(ethylene oxide)-b-Poly(e- caprolactone) block copolymer. Langmuir 2007; 23: 2126-32.